Cargando…
Purine Synthesis Inhibitor L-Alanosine Impairs Mitochondrial Function and Stemness of Brain Tumor Initiating Cells
Glioblastoma (GBM) is a lethal brain cancer exhibiting high levels of drug resistance, a feature partially imparted by tumor cell stemness. Recent work shows that homozygous MTAP deletion, a genetic alteration occurring in about half of all GBMs, promotes stemness in GBM cells. Exploiting MTAP loss-...
Autores principales: | Singh, Simranjit X., Yang, Rui, Roso, Kristen, Hansen, Landon J., Du, Changzheng, Chen, Lee H., Greer, Paula K., Pirozzi, Christopher J., He, Yiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025092/ https://www.ncbi.nlm.nih.gov/pubmed/35453502 http://dx.doi.org/10.3390/biomedicines10040751 |
Ejemplares similares
-
Increased Tumor Control Rates in Murine Fibrosarcoma by Combined Therapy with L‐Alanosine and Radiation
por: Hong, Seong Su, et al.
Publicado: (1989) -
MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarization
por: Hansen, Landon J., et al.
Publicado: (2022) -
The Intersection of Purine and Mitochondrial Metabolism in Cancer
por: De Vitto, Humberto, et al.
Publicado: (2021) -
Mitochondrial Basis for Immune Deficiency: Evidence from Purine Nucleoside Phosphorylase–Deficient Mice
por: Arpaia, Enrico, et al.
Publicado: (2000) -
The Purins
por: Hopkins, Henry Reed
Publicado: (1910)